Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Johnson & johnson symbols : Rprx save search
Royalty Pharma to Announce First Quarter 2024 Financial Results on May 9, 2024
Published: 2024-04-19 (Crawled : 12:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.83%
H: 1.35%
C: 1.2%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: 1.07%
H: 1.22%
C: 1.11%
first pharma royalty financial results
Royalty Pharma Declares Second Quarter 2024 Dividend
Published: 2024-04-17 (Crawled : 12:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.04%
H: 0.28%
C: -0.16%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: -1.5%
H: 0.84%
C: 0.25%
pharma royalty
Royalty Pharma to Present at TD Cowen’s 44th Annual Health Care Conference
Published: 2024-02-28 (Crawled : 21:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.56%
H: 0.12%
C: -0.38%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: 0.29%
H: 0.08%
C: -1.17%
pharma conference health care royalty
Royalty Pharma Reports Q4 and Full Year 2023 Results
Published: 2024-02-15 (Crawled : 12:30) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.19%
H: 1.6%
C: 1.24%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: 1.26%
H: 3.99%
C: 1.21%
pharma year royalty results
Royalty Pharma To Announce Fourth Quarter And Full Year 2023 Financial Results On February 15, 2024
Published: 2024-01-30 (Crawled : 21:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.49%
H: 0.14%
C: -0.94%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: 0.07%
H: 0.44%
C: -1.08%
pharma year royalty financial results
Royalty Pharma Announces Dividend Increase
Published: 2024-01-19 (Crawled : 13:30) - royaltypharma.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.67%
H: 0.0%
C: 0.0%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: 0.57%
H: 3.21%
C: 3.09%
pharma royalty
Royalty Pharma Highlights Accomplishments and Provides Business Update at 42nd Annual J.P. Morgan Healthcare Conference
Published: 2024-01-08 (Crawled : 12:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.47%
H: 0.0%
C: 0.0%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: 0.0%
H: 1.84%
C: 1.82%
pharma conference business update royalty
Royalty Pharma to Present at the Evercore ISI 6th Annual HealthCONx Conference
Published: 2023-11-27 (Crawled : 21:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.09%
H: 0.0%
C: 0.0%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: -0.04%
H: 0.39%
C: -0.15%
pharma conference royalty
Teva and Royalty Pharma Collaborate to Further Accelerate Olanzapine LAI Program
Published: 2023-11-13 (Crawled : 13:30) - biospace.com/
TEVA | $12.86 0.63% 0.0% 10M
|
Health Technology
|
| O: -0.92%
H: 4.53%
C: 2.56%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: -0.44%
H: 0.59%
C: 0.04%
pharma royalty teva program
Royalty Pharma and Teva Collaborate to Further Accelerate Olanzapine Lai Program
Published: 2023-11-13 (Crawled : 13:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.5%
H: 0.0%
C: 0.0%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: -0.44%
H: 0.59%
C: 0.04%
pharma royalty teva program
Royalty Pharma Reports Third Quarter 2023 Results
Published: 2023-11-08 (Crawled : 12:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.4%
H: 0.32%
C: -0.66%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: -1.38%
H: 1.77%
C: 1.66%
PTCT | News S | $25.32 2.55% 2.49% 3.9M
|
Health Technology
|
| O: -0.05%
H: 0.0%
C: -3.21%
ASND | $140.19 -0.5% -0.5% 270K
|
Health Technology
|
| O: -1.78%
H: 1.24%
C: 0.32%
pharma royalty results
Royalty Pharma Announces Agreement to Purchase Up to $1.5 Billion of PTC Therapeutics’ Royalty on Evrysdi
Published: 2023-10-19 (Crawled : 12:00) - globenewswire.com
PPRUF | $358.55 37.56% 1.5K
|
Consumer Non-Durables
|
| O: -0.57%
H: 1.09%
C: 0.98%
PPRUY | $36.0023 -0.11% 220K
|
Manufacturing
|
| O: 1.4%
H: 0.53%
C: -0.81%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.73%
H: 0.0%
C: 0.0%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: 0.15%
H: 3.45%
C: 2.22%
PTCT | News S | $25.32 2.55% 2.49% 3.9M
|
Health Technology
|
| O: 3.46%
H: 19.19%
C: 11.13%
pharma royalty evrysdi agreement
Royalty Pharma Declares Fourth Quarter 2023 Dividend
Published: 2023-10-16 (Crawled : 20:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.61%
H: 0.0%
C: 0.0%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: -0.11%
H: 2.08%
C: 1.97%
pharma royalty
Royalty Pharma To Announce Third Quarter 2023 Financial Results On November 8, 2023
Published: 2023-10-11 (Crawled : 20:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.87%
H: 0.0%
C: 0.0%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: 0.15%
H: 0.22%
C: -0.29%
pharma royalty financial results
Royalty Pharma Appoints Eric Schneider as Chief Technology Officer
Published: 2023-09-21 (Crawled : 12:30) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.52%
H: 0.57%
C: -0.56%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: -0.38%
H: 0.02%
C: -3.97%
pharma royalty technology
Royalty Pharma and Ascendis Pharma Enter Into $150 Million Royalty Funding Agreement
Published: 2023-09-05 (Crawled : 20:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: 0.41%
H: 0.07%
C: -1.86%
ASND | $140.19 -0.5% -0.5% 270K
|
Health Technology
|
| O: 3.69%
H: 2.93%
C: 0.53%
pharma royalty funding agreement
Ascendis Pharma and Royalty Pharma Enter into $150 Million Royalty Funding Agreement
Published: 2023-09-05 (Crawled : 20:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.37%
H: 0.0%
C: 0.0%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: 0.41%
H: 0.07%
C: -1.86%
ASND | $140.19 -0.5% -0.5% 270K
|
Health Technology
|
| O: 3.69%
H: 2.93%
C: 0.53%
pharma royalty funding agreement
Royalty Pharma to Present at Upcoming Investor Conferences
Published: 2023-09-05 (Crawled : 12:30) - globenewswire.com
MS | News 0 d | $90.66 0.44% 0.07% 8.1M
|
Finance
|
| O: 0.01%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.58%
H: 0.0%
C: 0.0%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: -0.17%
H: 0.2%
C: -2.38%
pharma royalty
Royalty Pharma and Ferring Pharmaceuticals Enter into US $500 million Royalty Agreement for New Intravesical Gene Therapy Adstiladrin® (nadofaragene firadenovec-vncg)
Published: 2023-08-24 (Crawled : 08:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -1.1%
H: 0.0%
C: 0.0%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: 0.0%
H: 0.72%
C: -0.4%
adstiladrin pharma pharmaceuticals royalty agreement therapy
Royalty Pharma Reports Second Quarter 2023 Results
Published: 2023-08-08 (Crawled : 11:00) - globenewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 2.1%
H: 0.0%
C: 0.0%
RPRX | News | $28.17 1.0% 0.99% 1.8M
|
Health Technology
|
| O: -1.6%
H: 0.0%
C: 0.0%
pharma royalty results
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.